Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis

BACKGROUND: Hyperuricemia is reported to be related to rapid progression of renal function in patients with chronic kidney disease (CKD). Allopurinol, a uric acid lowering agent, protects renal progression. However, it is not widely used in patients with CKD because of its serious adverse event. Feb...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sollip, Kim, Hyun-Jung, Ahn, Hyeong-Sik, Oh, Se Won, Han, Kum Hyun, Um, Tae-Hyun, Cho, Chong-Rae, Han, Sang Youb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Nephrology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592895/
https://www.ncbi.nlm.nih.gov/pubmed/28904879
http://dx.doi.org/10.23876/j.krcp.2017.36.3.274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592895/
https://www.ncbi.nlm.nih.gov/pubmed/28904879
http://dx.doi.org/10.23876/j.krcp.2017.36.3.274

Ejemplares similares